Acun 2005.

Methods	Setting: Hospital OPD in Turkey Design: parallel group trial Length of intervention period: 52 weeks Randomisation: yes; method not described Masking: open label Excluded: stated (none) Withdrawals: not stated Baseline characteristics: comparable between groups Jadad score: 1
Participants	100 children: 51M 49F Age range: 4‐11.5 years Inclusion criteria: symptomatic 2 x week; recent diagnosis of moderate persistent asthma; nocturnal symptoms >1 night per week; within 10th‐90th centile
Interventions	FP: 125 BID (250mcg/d) BUD: 200 BID (400mcg/d) Inhaler device: MDI
Outcomes	Growth rate
Notes
Risk of bias
Bias	Authors' judgement	Support for judgement
Adequate sequence generation?	Unclear risk	Described as randomised; other information not available
Allocation concealment?	Unclear risk	Information not available
Blinding? All outcomes	High risk	Open label study